Early and Maintained Response Levels in Psoriasis Patients Treated with Tildrakizumab. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s41, 2020. DOI: 10.25251/skin.4.supp.41. Disponível em: https://skin.dermsquared.com/skin/article/view/990. Acesso em: 28 apr. 2025.